TL1AV84-L251(fw)

General Information


DRACP ID  DRACP05050

Peptide Name   TL1AV84-L251(fw)

Sequence  YTYGLCTSSR

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C49H75N13O17S

Absent amino acids  ADEFHIKMNPQVW

Common amino acids  STY

Mass  131097

Pl  8.51

Basic residues  1

Acidic residues  0

Hydrophobic residues  1

Net charge  1

Boman Index  -2000

Hydrophobicity  -42

Aliphatic Index  39

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  2980

Absorbance 280nm  331.11

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 20675618

Title  Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding

Doi 10.1093/gerona/glq129

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.